LAST PRICE - AT THE CLOSE
EMRAF is UP 3% since the begininning of the year
EMRAF is UP 3% ABOVE 20 day SMA
EMRAF is UP 9% ABOVE 200 day SMA
PROFITABLE: YES
EPS: $0.328
EARNINGS MOMENTUM: N/A
N/A INCREASE IN QTRLY EARNINGS
P/E RATIO IS: 20.7249
INCOME TO DEBT RATIO: 0.04
 |
THE STOCK IS 26.2% AWAY FROM ALL-TIME HIGHS OF $52.56 |
 |
EMRAF IS UP 3% SINCE THE BEGINNING OF THE YEAR |
 |
EMRAF IS UP 1% OVER THE PAST 12 MONTHS |
 |
EMRAF IS UP 6% OVER THE PAST 1 MONTH |
 |
1% OF ALL EMRAF INVESTORS ARE BETTING AGAINST EMRAF |
 |
NUM INVESTORS SHORT EMRAF HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|---|---|
 | New 60 minute low. | 09/18 |
 | Opening range breakd... | 09/18 |
 | 60 minute MACD cross... | 09/18 |
 | 60 minute MACD cross... | 09/18 |
 | 60 minute MACD cross... | 09/18 |
 |
EMRAF moved up 0 in the previous minute |
 |
EMRAF is up 0.03 over the last hour |
 |
EMRAF is up 3.4% over the last 5 days |
 |
EMRAF is 1.3 above its 8 day SMA |
| $38.81 |   DAY |
$38.82 |
| $39.05 | PREVIOUS DAY |
$39.24 |
| $37.52 |  WEEK |
$39.38 |
| $36.80 | MONTH |
$39.38 |
| $31.85 | YEAR |
$39.99 |
EMRAF is mentioned N/A less than normal on 
EMRAF is mentioned N/A times in an average day on 
